In addition recombinant IL15 has also been shown to be presented by B-CLL tumor cells to NK cells in vitro where it leads to NK activation and subsequent tumor cell lysis [45]. The gene discussed is IL15; the disease is B-cell chronic lymphocytic leukemia.